Epigenetic protein families: a new frontier for drug discovery - PubMed (original) (raw)

Review

. 2012 Apr 13;11(5):384-400.

doi: 10.1038/nrd3674.

Affiliations

Review

Epigenetic protein families: a new frontier for drug discovery

Cheryl H Arrowsmith et al. Nat Rev Drug Discov. 2012.

Abstract

Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases. At the molecular level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones. Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-containing proteins and proteins that bind to methylated histones. These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains. In this article, we discuss the known links with disease, basic molecular mechanisms of action and recent progress in the pharmacological modulation of each class of proteins.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mutat Res. 2008 Dec 1;647(1-2):21-9 - PubMed
    1. Structure. 2011 Sep 7;19(9):1262-73 - PubMed
    1. Nature. 2007 Nov 29;450(7170):712-6 - PubMed
    1. J Biol Chem. 2010 Sep 10;285(37):28553-64 - PubMed
    1. Hum Mol Genet. 2010 Jul 15;19(14):2841-57 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources